Meta-Analysis Highlights Kidney and Heart Benefits Researchers conducted a meta-analysis of 11 large-scale clinical trials of GLP-1 receptor agonists involving a total of 85,373 people (67,769 people with type 2 diabetes and 17,604 people with overweight or obesity and cardiovascular disease but without diabetes)
we are partners in your wellness journey
Because we address hormonal factors alongside GLP-1, many patients especially men over 35 see faster results than they experienced with other programs
Improves Brain and Mental Health Studies show that BPC-157 protects brain cells and supports neurotransmitter balance
PlexusDx serves all 50 states and eliminates the insurance barrier that prevents many people from accessing tirzepatide
In our latest blog, Sahithi Vemula unpacks how a new era of prescription-to-OTC switches could make safe, effective medicines more accessible than ever: bit.ly/3WQxHH1 To view or add a comment, sign in This article contains my thoughts on an FDA plan to merge the medical product manufacturing inspectorate with the clinical trial compliance inspectorate (known as Bioresearch Monitoring or BIMO)
